NLM Logo

VEBEP regimen MeSH Supplementary Concept Data 2024


MeSH Supplementary
VEBEP regimen
Unique ID
C090401
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C090401
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Bleomycin
Cyclophosphamide
Etoposide
Prednisone
Epirubicin
Frequency
8
Note
chemotherapy regimen consisting of etoposide, epirubicin, bleomycin, cyclophosphamide and prednisone; used in salvage treatment of stage IA-IIA Hodgkin's disease
Source
Int J Radiat Oncol Biol Phys 1994 Nov 15;30(4):813-9
Date of Entry
1994/12/14
Revision Date
2000/11/30
VEBEP regimen Preferred
page delivered in 0.004s